The release of interleukin (IL)-1α from necroptosis oncogenic cells generally promotes DCs secreting IL-12 to amplify anti-cancer immunity40, but sometimes necroptosis-derived IL-1α fosters tumor growth41,42. Here, IL1A is linked to cancer.